Come dive into one of the curiously delightful conversations overheard at National Geographic’s headquarters, as we follow explorers, photographers, and scientists to the edges of our big, weird, beautiful world. Hosted by Peter Gwin and Amy Briggs.
…
continue reading
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Breast Cancer | Oncology Today with Dr Neil Love: Adjuvant Therapy for ER-Positive Breast Cancer
MP4•Episode home
Manage episode 278530376 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Featuring a discussion on recent data with CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer with Prof Stephen Johnston, including the following topics:
- Management of Localized ER-Positive, HER2-Negative Early Breast Cancer: Recent Advances in Adjuvant Systemic Endocrine-Based Therapies — Stephen Johnston, MA, PhD (0:00)
- Case: A postmenopausal woman in her mid-50s with high-risk ER-positive, HER2-negative breast cancer who receives abemaciclib in addition to standard adjuvant hormonal therapy on the monarchE trial (24:37)
- Case: A woman in her mid-40s with recurrent ER-positive, HER2-negative breast cancer and oligometastatic disease to the bones (29:14)
- Case: A premenopausal woman in her mid-40s with ER-positive, HER2-negative breast cancer and a 21-gene assay Recurrence Score® of 19 (33:07)
1327 episodes
MP4•Episode home
Manage episode 278530376 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Featuring a discussion on recent data with CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer with Prof Stephen Johnston, including the following topics:
- Management of Localized ER-Positive, HER2-Negative Early Breast Cancer: Recent Advances in Adjuvant Systemic Endocrine-Based Therapies — Stephen Johnston, MA, PhD (0:00)
- Case: A postmenopausal woman in her mid-50s with high-risk ER-positive, HER2-negative breast cancer who receives abemaciclib in addition to standard adjuvant hormonal therapy on the monarchE trial (24:37)
- Case: A woman in her mid-40s with recurrent ER-positive, HER2-negative breast cancer and oligometastatic disease to the bones (29:14)
- Case: A premenopausal woman in her mid-40s with ER-positive, HER2-negative breast cancer and a 21-gene assay Recurrence Score® of 19 (33:07)
1327 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.